Cathie Wood's ARK ETFs have published their daily trades for Monday, November 25th, 2024, revealing a series of strategic adjustments across various sectors. The most significant dollar-value trade of the day was a sale of Tesla Inc (NASDAQ:TSLA) stock, with a total of 20,552 shares offloaded between the ARKK and ARKQ ETFs, amounting to a substantial $7,245,813.
In a notable buy, ARK's ARKQ ETF invested heavily in Amazon.com Inc (NASDAQ:AMZN), purchasing 19,747 shares valued at $3,892,528. This move signals ARK's continued confidence in the e-commerce giant, despite broader market fluctuations.
ARK also made a significant investment in 3IQ Ether Staking ETF (ETHQ.U), buying a total of 850,000 shares across the ARKW and ARKF ETFs, totaling $11,050,000. This purchase underscores ARK's increasing interest in cryptocurrency-related assets.
In the realm of technology and innovation, ARK's ARKQ ETF added 10,753 shares of Advanced Micro Devices Inc (NASDAQ:AMD) to its holdings, with a total value of $1,487,677. The investment aligns with ARK's focus on companies poised for growth in sectors like artificial intelligence and computing.
The ARKF ETF's largest buy was in Ibotta Inc (IBTA), with 68,442 shares acquired, valued at $4,833,374. This transaction continues a trend as ARK has been accumulating Ibotta shares, having bought 12,303 shares last Friday.
In the healthcare and genomics space, ARK's ARKG ETF sold 276,392 shares of Butterfly Network Inc (NYSE:BFLY) for $895,510 and bought 96,815 shares of Recursion Pharmaceuticals Inc (NASDAQ:RXRX) for $551,845. These trades indicate a rebalancing of ARK's portfolio in the rapidly evolving biotech industry.
Other notable trades included the purchase of 38,270 shares of Teradyne Inc (NASDAQ:TER) across the ARKK and ARKQ ETFs, amounting to $4,136,604. Additionally, ARK continued to divest from SoFi Technologies Inc (NASDAQ:SOFI), selling 487,850 shares through its ARKF ETF, valued at $7,610,460.
Smaller trades included purchases of shares in Absci Corp (NASDAQ:ABSI), Blade Air Mobility Inc (NASDAQ:BLDE), Illumina Inc (NASDAQ:ILMN), and Pacific Biosciences (NASDAQ:PACB) of California Inc (NASDAQ:PACB), as well as sales of shares in Genius Sports Ltd (NYSE:GENI), Palantir Technologies Inc (NYSE:NYSE:PLTR), Rocket Lab USA Inc (NASDAQ:RKLB), Repare Therapeutics Inc (NASDAQ:RPTX), and Senti Biosciences Inc (NASDAQ:SNTI).
Investors following ARK's movements can discern a strategy that involves both bolstering positions in high-conviction stocks and trimming holdings in others to navigate the market's changing tides.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.